ESC TV Today – Your Cardiovascular News Season 3 - Ep.15 : Colchicine for secondary prevention - An algorithmic approach to the workup of syncope
6 snips
May 8, 2025 Carlos Aguiar, a cardiologist who presents Cardiology This Week, delves into recent advances in cardiovascular care. He discusses the promising role of colchicine in preventing cardiovascular events, juxtaposed with recent trial findings. The conversation also explores the complexities of diagnosing syncope, especially in older adults, and emphasizes the importance of understanding its mechanisms for better treatment outcomes. Additionally, the Cybis II trial is highlighted for establishing beta blockers as vital therapy in chronic heart failure management.
AI Snips
Chapters
Transcript
Episode notes
TAVI and PCI Procedure Safety
- Combined TAVI and complex PCI procedures have more adverse events than staged ones mainly due to bleeding and vascular complications.
- Staged procedures are preferred for patient safety in TAVI and PCI.
T-wave Inversions Signal Cardiomyopathy
- Abnormal T-wave inversions in young healthy individuals can indicate underlying cardiomyopathy.
- Deeper and widespread T-wave inversions raise suspicion for cardiomyopathy needing further evaluation.
Reassessing Colchicine’s Efficacy
- Early colchicine trials may have overestimated benefits due to trial design and subgroup effects.
- Recent larger trials including CLEAR-SYNERGY show no significant colchicine benefit post-MI, suggesting regression to the mean.